HULL THOMAS DAVID III 4

What Happened
Thomas David Hull III, President & CEO and a director of Kewaunee Scientific Corp (KEQU), was granted 15,195 restricted stock units (RSUs) on June 24, 2026. The award is reported as a derivative acquisition at a $0.00 per-unit price (no cash paid). The RSUs represent contingent rights to receive one share per unit if and when they vest.

Key Details

• Transaction date: 2026-06-24; Form 4 filed: 2026-06-25 (appears timely).
• Amount: 15,195 RSUs; acquisition price reported as $0.00 (non-cash award).
• Vesting: RSUs vest in three equal annual installments beginning June 30, 2027, subject to continued employment (footnotes F1 & F2).
• Shares owned after transaction: not specified in the provided filing details.
• Transaction code: "A" (award/grant); this is a compensation grant, not an open-market purchase or sale.

Context
RSU grants are a common form of executive compensation and do not indicate an immediate purchase or sale of shares — the units convert to actual shares only as they vest. Because this is a grant at $0, there was no cash exchanged at the time of grant. This filing simply notifies investors of the award and the vesting schedule; it does not by itself signal buying or selling activity.